Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY

Rhee, JJ; Jardine, MJ; Chertow, GM; Mahaffey, KW

Rhee, JJ (corresponding author), Stanford Univ, Dept Med, Div Nephrol, Sch Med, 1070 Arastradero Rd,Suite 3C3109, Stanford, CA 94304 USA.

DIABETES OBESITY & METABOLISM, 2020; 22 (): 46

Abstract

In the past decade, many cardiovascular outcome trials (CVOT) on the efficacy and safety of glucose-lowering agents have been completed. Amongst newer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索